Healthcare
[WEBINAR] Biopharma Dealmaking 2026: Trends, Shifts, and What Comes Next
In this webinar, Ipsos will frame the latest dealmaking trends using recent transactions and market data, followed by a moderated discussion with active investors on what is changing in valuation, deal structures, and decision criteria, and what this means for pharma acquirers and innovator biotechs preparing for partnering conversations.
Healthcare
Survey
Ipsos Ideas: Vioxx Recall Hurt American's Confidence In FDA, Not Prescription Drugs
Healthcare
Survey
Dr. Jekyll and Mr. Hyde: Pharmaceutical Companies Contend with Drug Benefit and Risk Communications
442 - 450 of 483 items